| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2023 | REGENXBIO |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$91,000 | |
| 2023 | REGENXBIO |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$94,000 | |
| 2023 | REGENXBIO |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$90,000 | |
| 2023 | REGENXBIO |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$163,000 | |
| 2022 | REGENXBIO |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$70,000 | |
| 2022 | REGENXBIO |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$70,000 | |
| 2022 | REGENXBIO |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$82,000 | |
| 2022 | REGENXBIO |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$150,000 | |
| 2021 | REGENXBIO |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$60,000 | |
| 2021 | REGENXBIO |
3rd Quarter (July 1 - Sep 30) AMENDED |
$75,000 |
| Firm | Filings | Expenses |
|---|---|---|
| REGENXBIO | 24 | $1,740,000 |
| Issue | Activities |
|---|---|
| Copyright/Patent/Trademark | 22 |
| Health Issues | 22 |
| Trade (domestic/foreign) | 21 |
| Immigration | 19 |
| Taxation/Internal Revenue Code | 8 |